Novo Nordisk joins top ten of most profitable pharma firms worldwide

The Danish pharmaceutical firm has entered the top ten of the most profitable firms in the industry in 2021. Competitors Eli Lilly and Sanofi didn’t make the cut, while Novartis is in the front of the pack.

Photo: Novo Nordisk / PR/Henning Larsen Architects

With USD 24bn on the bottom line in 2021, Swiss Novartis lands the top spot as the most profitable pharmaceutical firm in the world, according to a ranking of the top ten pharma firms based on net incomes made by Industry media Fierce Pharma.

Novartis might find it difficult to stay on top, however, as the firm was boosted by Roche buying back Novartis’s share investment for CHF 19bn last year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs